MBio Diagnostics

MBio is leading a new era in rapid, on-the-spot clinical diagnostics and sample testing. Our portable MBio multiplex analyzer and disposable cartridge enable low-cost, rapid answers in 1 to 20 minutes. MBio aims to be the platform of choice for leading providers and users of clinical and analytical testing services in all market segments including: medical, veterinary, environmental, food, agricultural and military. With a broad patent portfolio backed by over 8 years of development expertise and milestones, MBio’s platform has been validated through multiple partnerships with industry, academia and government. We are proud of our many scientific publications supporting our company and the MBio Array System. Our patented LightDeck® technology does not require sample prep and can be designed to detect all key analytes including proteins, cells, nucleic acids and small molecules.
Company growth
Boulder, US
Size (employees)
19 (est)+12%
MBio Diagnostics was founded in 2009 and is headquartered in Boulder, US

Key People at MBio Diagnostics

Christopher J. Myatt

Christopher J. Myatt

Founder and Chief Executive Officer
Michael J. Lochhead

Michael J. Lochhead

Vice President
Sarah Hatcher

Sarah Hatcher

President and Counsel

MBio Diagnostics Office Locations

MBio Diagnostics has office in Boulder
Boulder, US

MBio Diagnostics Metrics

MBio Diagnostics Summary

Founding Date


Total Funding

$8.3 M

Latest funding size

$6.3 M

Time since last funding

almost 2 years
We estimate that MBio Diagnostics's latest funding round in May 2015 was $6.3 M. In total, MBio Diagnostics has raised $8.3 M
We estimate that MBio Diagnostics's current employees are approximately 29% female and 71% male.

Market Position – platform, testing services, diagnostics, Health, clinics, life sciences

MBio Diagnostics Company Life

You may also be interested in